Biblio
Export 1382 results:
Author Title [ Type
Filters: First Letter Of Last Name is G [Clear All Filters]
“Sex Impact on Tau-Aggregation and Postsynaptic Protein Levels in the P301L Mouse Model of Tauopathy.”, J Alzheimers Dis, vol. 56, no. 4, pp. 1279-1292, 2017.
, “Sex Differences in the Psychophysical Response to Contact Heat in Moderate Cognitive Impairment Alzheimer's Disease: A Cross-Sectional Brief Report.”, J Alzheimers Dis, vol. 60, no. 4, pp. 1633-1640, 2017.
, “Severity Distribution of Alzheimer's Disease Dementia and Mild Cognitive Impairment in the Framingham Heart Study.”, J Alzheimers Dis, vol. 79, no. 2, pp. 807-817, 2020.
, “Severe Agitation in Dementia: An Explorative Secondary Data Analysis on the Prevalence and Associated Factors in Nursing Home Residents.”, J Alzheimers Dis, vol. 66, no. 4, pp. 1463-1470, 2018.
, “Serum Non-Ceruloplasmin Non-Albumin Copper Elevation in Mild Cognitive Impairment and Dementia due to Alzheimer's Disease: A Case Control Study.”, J Alzheimers Dis, vol. 61, no. 3, pp. 907-912, 2018.
, “Serum Hepcidin Levels in Cognitively Normal Older Adults with High Neocortical Amyloid-β Load.”, J Alzheimers Dis, vol. 76, no. 1, pp. 291-301, 2020.
, “Serum C-Peptide, Visfatin, Resistin, and Ghrelin are Altered in Sporadic and GRN-Associated Frontotemporal Lobar Degeneration.”, J Alzheimers Dis, vol. 61, no. 3, pp. 1053-1060, 2018.
, “Serum Copper is not Altered in Frontotemporal Lobar Degeneration.”, J Alzheimers Dis, vol. 63, no. 4, pp. 1427-1432, 2018.
, “Serum Adiponectin Levels, Neuroimaging, and Cognition in the Mayo Clinic Study of Aging.”, J Alzheimers Dis, vol. 53, no. 2, pp. 573-81, 2016.
, “Serotonin Selective Reuptake Inhibitor Treatment Improves Cognition and Grey Matter Atrophy but not Amyloid Burden During Two-Year Follow-Up in Mild Cognitive Impairment and Alzheimer's Disease Patients with Depressive Symptoms.”, J Alzheimers Dis, vol. 65, no. 3, pp. 793-806, 2018.
, “Serotonin Degeneration and Amyloid-β Deposition in Mild Cognitive Impairment: Relationship to Cognitive Deficits.”, J Alzheimers Dis, vol. 96, no. 1, pp. 215-227, 2023.
, “Sensitivity of Neuropsychological Tests to Identify Cognitive Decline in Highly Educated Elderly Individuals: 12 Months Follow up.”, J Alzheimers Dis, vol. 49, no. 3, pp. 607-16, 2016.
, “Sensing of Alzheimer's Disease and Multiple Sclerosis Using Nano-Bio Interfaces.”, J Alzheimers Dis, vol. 59, no. 4, pp. 1187-1202, 2017.
, “Sembragiline in Moderate Alzheimer's Disease: Results of a Randomized, Double-Blind, Placebo-Controlled Phase II Trial (MAyflOwer RoAD).”, J Alzheimers Dis, vol. 58, no. 4, pp. 1217-1228, 2017.
, “Sembragiline in Moderate Alzheimer's Disease: Results of a Randomized, Double-Blind, Placebo-Controlled Phase II Trial (MAyflOwer RoAD).”, J Alzheimers Dis, vol. 58, no. 4, pp. 1217-1228, 2017.
, “Sembragiline in Moderate Alzheimer's Disease: Results of a Randomized, Double-Blind, Placebo-Controlled Phase II Trial (MAyflOwer RoAD).”, J Alzheimers Dis, vol. 58, no. 4, pp. 1217-1228, 2017.
, “Self-Reported Change in Quality of Life with Retirement and Later Cognitive Decline: Prospective Data from the Nurses' Health Study.”, J Alzheimers Dis, vol. 52, no. 3, pp. 887-98, 2016.
, “Self-Perceived Quality of Life Among Patients with Alzheimer's Disease: Two Longitudinal Models of Analysis.”, J Alzheimers Dis, vol. 52, no. 3, pp. 999-1012, 2016.
, “Self-Consciousness in Patients with Behavioral Variant Frontotemporal Dementia.”, J Alzheimers Dis, vol. 49, no. 4, pp. 1021-9, 2016.
, “Self-Consciousness Deficits in Alzheimer's Disease and Frontotemporal Dementia.”, J Alzheimers Dis, vol. 55, no. 4, pp. 1437-1443, 2017.
, “Self- and Informant-Reported Memory Complaints: Frequency and Severity in Cognitively Intact Individuals and those with Mild Cognitive Impairment and Neurodegenerative Dementias.”, J Alzheimers Dis, vol. 65, no. 3, pp. 1011-1027, 2018.
, “Selenium Levels in Serum, Red Blood Cells, and Cerebrospinal Fluid of Alzheimer's Disease Patients: A Report from the Australian Imaging, Biomarker & Lifestyle Flagship Study of Ageing (AIBL).”, J Alzheimers Dis, vol. 57, no. 1, pp. 183-193, 2017.
, “Selective Peripheral Taste Dysfunction in APP/PS1 Mutant Transgenic Mice.”, J Alzheimers Dis, 2020.
, “A Selection of Important Genes and Their Correlated Behavior in Alzheimer's Disease.”, J Alzheimers Dis, vol. 65, no. 1, pp. 193-205, 2018.
, “Searching for Primary Predictors of Conversion from Mild Cognitive Impairment to Alzheimer's Disease: A Multivariate Follow-Up Study.”, J Alzheimers Dis, vol. 52, no. 1, pp. 133-43, 2016.
,